loadpatents
name:-0.014281988143921
name:-0.013581037521362
name:-0.0039949417114258
Andersson; Borje S. Patent Filings

Andersson; Borje S.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Andersson; Borje S..The latest application filed is for "parenteral formulations of lipophilic pharmaceutical agents and methods for preparing and using the same".

Company Profile
5.16.13
  • Andersson; Borje S. - Houston TX
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Parenteral formulations of lipophilic pharmaceutical agents and methods for preparing and using the same
Grant 11,045,466 - Andersson , et al. June 29, 2
2021-06-29
Parenteral Formulations Of Lipophilic Pharmaceutical Agents And Methods For Preparing And Using The Same
App 20200147076 - ANDERSSON; Borje S. ;   et al.
2020-05-14
Formulations of intraarticular pharmaceutical agents and methods for preparing and using the same
Grant 10,646,574 - Tarrand , et al.
2020-05-12
Parenteral formulations of lipophilic pharmaceutical agents and methods for preparing and using the same
Grant 10,548,890 - Andersson , et al. Fe
2020-02-04
Azole Pharmaceutical Formulations For Parenteral Administration And Methods For Preparing And Using The Same As Treatment Of Dis
App 20190240216 - ANDERSSON; Borje S. ;   et al.
2019-08-08
Azole pharmaceutical formulations for parenteral administration and methods for preparing and using the same as treatment of diseases sensitive to azole compounds
Grant 10,307,418 - Andersson , et al.
2019-06-04
Parenteral Formulations Of Lipophilic Pharmaceutical Agents And Methods For Preparing And Using The Same
App 20180296556 - ANDERSSON; Borje S. ;   et al.
2018-10-18
Parenteral formulations of lipophilic pharmaceutical agents and methods for preparing and using the same
Grant 10,028,949 - Andersson , et al. July 24, 2
2018-07-24
Parenteral formulations of lipophilic pharmaceutical agents and methods for preparing and using the same
Grant 9,724,345 - Andersson , et al. August 8, 2
2017-08-08
Formulations Of Intraarticular Pharmaceutical Agents And Methods For Preparing And Using The Same
App 20170209587 - TARRAND; Jeffrey J. ;   et al.
2017-07-27
Parenteral Formulations Of Lipophilic Pharmaceutical Agents And Methods For Preparing And Using The Same
App 20170172971 - ANDERSSON; Borje S. ;   et al.
2017-06-22
Parenteral Formulations Of Lipophilic Pharmaceutical Agents And Methods For Preparing And Using The Same
App 20160346278 - ANDERSSON; Borje S. ;   et al.
2016-12-01
Parenteral formulations of lipophilic pharmaceutical agents and methods for preparing and using the same
Grant 9,364,433 - Andersson , et al. June 14, 2
2016-06-14
Azole Pharmaceutical Formulations For Parenteral Administration And Methods For Preparing And Using The Same As Treatment Of Diseases Sensitive To Azole Compounds
App 20140031366 - Andersson; Borje S. ;   et al.
2014-01-30
Parenteral Formulations Of Lipophilic Pharmaceutical Agents And Methods For Preparing And Using The Same
App 20120277249 - Andersson; Borje S. ;   et al.
2012-11-01
Antifungal pimaricin compositions and therapeutic methods employing same
Grant 7,220,726 - Andersson , et al. May 22, 2
2007-05-22
Pharmacologically acceptable solvent vehicles
Grant 7,153,838 - Andersson , et al. December 26, 2
2006-12-26
Topical formulations of natamycin/pimaricin
Grant 6,844,004 - Andersson January 18, 2
2005-01-18
Parenteral pimaricin as treatment of systemic infections
App 20040037907 - Andersson, Borje S. ;   et al.
2004-02-26
Topical formulations of natamycin/pimaricin
App 20030129225 - Andersson, Borje S.
2003-07-10
Pharmacologically Acceptable Solvent Vehicles
App 20020155141 - ANDERSSON, BORJE S.
2002-10-24
Parenteral paclitaxel in a stable non-toxic formulation
Grant 5,877,205 - Andersson March 2, 1
1999-03-02
Parenteral busulfan for treatment of malignant disease
Grant 5,430,057 - Andersson , et al. July 4, 1
1995-07-04
Selective elimination of malignant cells from bone marrow by bis (acyloxy) propylphosphoramidates
Grant 5,055,459 - Andersson , et al. October 8, 1
1991-10-08

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed